JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M209560200 on September 26, 2002

J. Biol. Chem., Vol. 277, Issue 48, 46073-46078, November 29, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/48/46073    most recent
M209560200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrews, A.-L.
Right arrow Articles by Davies, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrews, A.-L.
Right arrow Articles by Davies, D. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Kinetic Analysis of the Interleukin-13 Receptor Complex*

Allison-Lynn Andrews, John W. HollowayDagger , Sarah M. Puddicombe, Stephen T. Holgate, and Donna E. Davies§

From the Infection, Inflammation and Repair Division, School of Medicine, University of Southampton, 97 Tremona Rd., Southampton General Hospital, Southampton SO16 6YD, United Kingdom

Interleukin (IL)-13 is a key cytokine associated with the asthmatic phenotype. It signals via its cognate receptor, a complex of IL-13 receptor alpha 1 chain (IL-13Ralpha 1) with IL-4Ralpha ; however, a second protein, IL-13Ralpha 2, also binds IL-13. To determine the binding contributions of the individual components of the IL-13 receptor to IL-13, we have employed surface plasmon resonance and equilibrium binding assays to investigate the ligand binding characteristics of shIL-13Ralpha 1, shIL-13Ralpha 2, and IL-4Ralpha . shIL-13Ralpha 1 bound IL-13 with moderate affinity (KD = 37.8 ± 1.8 nM, n = 10), whereas no binding was observed for hIL-4Ralpha . In contrast, shIL-13Ralpha 2 produced a high affinity interaction with IL-13 (KD = 2.49 ± 0.94 nM n = 10). IL-13Ralpha 2 exhibited the binding characteristics of a negative regulator with a fast association rate and an exceptional slow dissociation rate. Although IL-13 interacted weakly with IL-4Ralpha on its own (KD > 50 µM), the presence of hIL-4Ralpha significantly increased the affinity of shIL-13Ralpha 1 for IL-13 but had no effect on the binding affinity of IL-13Ralpha 2. Detailed kinetic analyses of the binding properties of the heteromeric complexes suggested a sequential mechanism for the binding of IL-13 to its signaling receptor, in which IL-13 first binds to IL-13Ralpha 1 and this then recruits IL-4Ralpha to stabilize a high affinity interaction.


* This work was supported in part by the Medical Research Council (MRC), United Kingdom (Grant G4500010).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger An MRC Training Fellow.

§ To whom correspondence should be addressed. Tel.: 23-80-798-523; Fax: 23-80-777-996; E-mail: donnad@soton.ac.uk.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. T. Kasaian, X.-Y. Tan, M. Jin, L. Fitz, K. Marquette, N. Wood, T. A. Cook, J. Lee, A. Widom, R. Agostinelli, et al.
Interleukin-13 Neutralization by Two Distinct Receptor Blocking Mechanisms Reduces Immunoglobulin E Responses and Lung Inflammation in Cynomolgus Monkeys
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 882 - 892.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A.-L. Andrews, J. W. Holloway, S. T. Holgate, and D. E. Davies
IL-4 Receptor {alpha} Is an Important Modulator of IL-4 and IL-13 Receptor Binding: Implications for the Development of Therapeutic Targets.
J. Immunol., June 15, 2006; 176(12): 7456 - 7461.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Arima, K. Sato, G. Tanaka, S. Kanaji, T. Terada, E. Honjo, R. Kuroki, Y. Matsuo, and K. Izuhara
Characterization of the Interaction between Interleukin-13 and Interleukin-13 Receptors
J. Biol. Chem., July 1, 2005; 280(26): 24915 - 24922.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.